| Thomas Phiambolis, MD | |
|
100 E Lancaster Ave, Jd Lankenau Pavilion, Mezzanine, Wynnewood, PA 19096-3450 | |
| (484) 476-1000 | |
| (484) 476-9000 |
| Full Name | Thomas Phiambolis |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 45 Years |
| Location | 100 E Lancaster Ave, Wynnewood, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144225905 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD023914E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
Mothers who breastfeed for a total of at least 15 months over one or more pregnancies may be less likely to develop multiple sclerosis (MS) compared with those who don't breastfeed at all or do so for up to four months, according to a study published in the July 12, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
The administration released guidance for the small business tax credit provision of the health law while the AMA asked for specific anti-trust treatment regarding accountable care organizations.
Children born with certain heart defects have impaired blood flow from the right ventricle to the pulmonary artery leading to the lungs, requiring implanted devices (known as right-ventricular outflow tract conduits) to maintain the flow. However, these conduits fail over time, and children typically face multiple open-heart operations during their lives to reopen the passage.
OncoGenex Pharmaceuticals, Inc. today announced that it has executed an initial agreement with Teva Pharmaceutical Industries Ltd. to regain rights to custirsen, an investigational compound currently being evaluated in Phase 3 clinical development as a treatment for prostate and lung cancers.
Our body reacts to blood loss by stimulating the production of red blood cells (erythrocytes). The cells of the hematopoietic (blood-forming) system in the bone marrow do so upon receipt of a signal by a hormone called erythropoietin, or Epo for short. This hormone is produced mainly by the kidney that increases the Epo level by up to a thousand-fold as a response to falling oxygen saturation of the blood.
› Verified 1 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
Mothers who breastfeed for a total of at least 15 months over one or more pregnancies may be less likely to develop multiple sclerosis (MS) compared with those who don't breastfeed at all or do so for up to four months, according to a study published in the July 12, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
The administration released guidance for the small business tax credit provision of the health law while the AMA asked for specific anti-trust treatment regarding accountable care organizations.
Children born with certain heart defects have impaired blood flow from the right ventricle to the pulmonary artery leading to the lungs, requiring implanted devices (known as right-ventricular outflow tract conduits) to maintain the flow. However, these conduits fail over time, and children typically face multiple open-heart operations during their lives to reopen the passage.
OncoGenex Pharmaceuticals, Inc. today announced that it has executed an initial agreement with Teva Pharmaceutical Industries Ltd. to regain rights to custirsen, an investigational compound currently being evaluated in Phase 3 clinical development as a treatment for prostate and lung cancers.
Our body reacts to blood loss by stimulating the production of red blood cells (erythrocytes). The cells of the hematopoietic (blood-forming) system in the bone marrow do so upon receipt of a signal by a hormone called erythropoietin, or Epo for short. This hormone is produced mainly by the kidney that increases the Epo level by up to a thousand-fold as a response to falling oxygen saturation of the blood.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Phiambolis, MD 100 E Lancaster Ave, Wynnewood, PA 19096-3450 Ph: (484) 476-1000 | Thomas Phiambolis, MD 100 E Lancaster Ave, Jd Lankenau Pavilion, Mezzanine, Wynnewood, PA 19096-3450 Ph: (484) 476-1000 |
News Archive
Mothers who breastfeed for a total of at least 15 months over one or more pregnancies may be less likely to develop multiple sclerosis (MS) compared with those who don't breastfeed at all or do so for up to four months, according to a study published in the July 12, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
The administration released guidance for the small business tax credit provision of the health law while the AMA asked for specific anti-trust treatment regarding accountable care organizations.
Children born with certain heart defects have impaired blood flow from the right ventricle to the pulmonary artery leading to the lungs, requiring implanted devices (known as right-ventricular outflow tract conduits) to maintain the flow. However, these conduits fail over time, and children typically face multiple open-heart operations during their lives to reopen the passage.
OncoGenex Pharmaceuticals, Inc. today announced that it has executed an initial agreement with Teva Pharmaceutical Industries Ltd. to regain rights to custirsen, an investigational compound currently being evaluated in Phase 3 clinical development as a treatment for prostate and lung cancers.
Our body reacts to blood loss by stimulating the production of red blood cells (erythrocytes). The cells of the hematopoietic (blood-forming) system in the bone marrow do so upon receipt of a signal by a hormone called erythropoietin, or Epo for short. This hormone is produced mainly by the kidney that increases the Epo level by up to a thousand-fold as a response to falling oxygen saturation of the blood.
› Verified 1 days ago
Dr. Akhnuwkh Jones, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 E Lancaster Ave, Wynnewood, PA 19096 Phone: 610-645-2000 | |
Amanda B Christini, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 100 E Lancaster Ave, 4 Pavilion, Suite 4303, Wynnewood, PA 19096 Phone: 484-476-6421 Fax: 484-476-3149 | |
Daniel Wang, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, 4 Pavilion Ste 4303, Wynnewood, PA 19096 Phone: 484-476-6421 Fax: 484-476-3149 | |
Xiaoling Yu, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 E Lancaster Ave, Wynnewood, PA 19096 Phone: 484-476-6421 | |
Dr. Eric Marc Russell, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, Wynnewood, PA 19096 Phone: 610-645-2000 | |
Dr. Jeremy Winthrop Gelber, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 330 Aubrey Rd, Wynnewood, PA 19096 Phone: 610-642-3999 | |
Dr. Scott Andrew Fink, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, Suite 252, Wynnewood, PA 19096 Phone: 610-896-7360 Fax: 610-896-5207 |